Replay available

Diploma (LSE:DPLM) Q4 2026 Earnings Call

Diploma (LSE:DPLM) reported Q4 2026 results on this call. Replay available.

Tue, November 17, 2026 at 4:00 AMendedReplay
Diploma (LSE:DPLM) Q4 2026 Earnings Call
Company
Diploma PLC (LSE:DPLM)
Period
Q4 2026 earnings call
Date
Tue, Nov 17, 2026, 4:00 AM ET
Replay
Watch the replay on this page · 53 min
Results news release
Diploma PLC Full Year Results 2026 · Tue, Nov 17, 2026

On 6ix: 6ix.com/event/diploma-plc-dplml-q4-2026-earnings-call

Replay

Transcript

Automated transcript · Written by software from the replay's audio. It can mishear names and figures; the replay is the record.

0:00 Good morning everyone. Thank you for joining us for Diploma's 2026 results update. As usual, I'm joined by our CFO, Wilson Ng. A couple of key messages before we get started from me. The first is we've had an excellent year, a real step change in our earnings, and really importantly, we've got strong momentum into the new year. Our growth is really broad-based across the portfolio. We've got good end market support making our growth more structural. We've had a record year for acquisitions with a few more in quarter one as well. We're investing in our people. And a big thanks to all my diploma colleagues out there for their brilliant contribution to our results.

0:51 The energy and the mood around the patch is really strong. So as we step into the new year, we will see naturally some moderation in the growth rates in quarter two, just with comps. but we're very very positive about another year and we're guiding to another very very positive year in 2027 and we're feeling very optimistic about our sustainable quality compounding. So I'm going to give you an overview, Wilson will come back and do the numbers and then I'll come back and do strategy and the business and as usual we'll do Q&A at the end. Okay, let's get started. So as I said, it's been an excellent year for Diploma. We balance ambitious earnings growth, up 45% in the year, with disciplined returns, 25% in the year. Together, key to sustainable quality compounding.

1:48 We've delivered a very strong performance across all our key financial metrics. Organic growth of 15%, reported growth 21%, operating profit up 42%, and all at margins of 26.5%, adding to our long-term compounding track record. Another fantastic performance from Peerless, but broad-based, double-digit organic growth across the rest of the Group too. The quality and diversity of our portfolio gives us exposure to attractive end markets, which support structural long-term organic growth, 11% on average over the last five years. It also gives us greater resilience. We accelerate organic growth with targeted acquisitions, and as I said, we've had a record year, 16 deals since the start of 2026, adding around 50 million of operating profit. CDM, our US defence business acquired in June, has started really well.

2:47 And we've added five deals since our Q3 trading update, including Elite, a US water pump business acquired in October. The pipeline is very healthy and there's plenty of balance sheet capacity. Overall, momentum is encouraging. The new year has started well. And after a big step forward in 2026, we're guiding to another strong year of sustainable quality compounding. A moment now to reflect. Diploma has been delivering compounded double-digit revenue and earnings growth for decades, and at great returns on capital. We've developed the strategy, we've injected more ambition, we've improved our execution and the compounding has accelerated with a step up in organic growth, acquisitions and margins.

3:41 And we're just getting started. The group's future is very promising. We continue to balance ambition with discipline. Our business model is robust. Our growth potential with structural support in fragmented markets is massive. We focus on cash, capital allocation and returns. And all driven by the depth and quality of our management, our powerful decentralised culture and our intense focus on execution. I'm really excited about our future. Our people and our culture deliver this. They make it sustainable. I'd like to thank again all of my brilliant colleagues. Their skill, energy and passion every day is what drives our success.

4:30 Building capability is the most important part of my job. We're investing in our talent, leadership development programmes and a new graduate cohort are examples. Our objective is long-term management succession in the businesses. We're also investing new resource into end market development, acquisition origination and our controls platform too. Our differentiated culture of commerciality, accountability and continuous improvement is thriving across the businesses. Engagement scores are again very high. And we complement that with a connectivity and performance ownership mentality across the group. The mood is energised. Now I'll hand over to Wilson to take you through the numbers.

5:26 Thank you, Jonny. Morning, everyone. So, turning to FY26, we've delivered an outstanding performance across all of our key metrics. Organic growth is our priority, so I'm really pleased with the 15% growth in the year, and total revenue was up 21%, including a 6% contribution from acquisitions. We've delivered 400 basis point increase in operating margin to 26.5%. In turn, driving very strong EPS growth of 45%, building our long-term track record. Strong cash conversion of 94% with notable growth in investment in working capital.

6:13 Leverage of 0.7 times with significant balance sheet headroom. High return on capital of 25.3%. And in line with our policy, we have grown the dividend by 5%. So summing all that up, I'm extremely pleased to be reporting another excellent performance. We have built a high quality and diverse portfolio that enables us to consistently deliver strong revenue growth. In FY26, we delivered total revenue growth of 21% with very strong organic growth of 15% and a 6% contribution from acquisitions. Controls increased organically by 25% driven by excellent execution in attractive end markets. This included great performances from Clarendon and IS Group and continued outstanding performance from Peerless.

7:08 Windy City grew strongly with an equal contribution from volume and the effective pass-through of copper pricing. SEALs achieved organic growth of 4% with sequential improvement in H2, up from 2% at H1. It's great to see high single-digit growth in North American SEALs through strong execution in its core business. International SEALs was challenging but performance continues to improve. Life Sciences delivered 1% organic growth. H2 performance was impacted by tough healthcare markets and a higher than normal rate of products coming out of the portfolio in the short term. These are businesses with defined product life cycles and the long-term product pipeline is healthy.

7:58 If we were to exclude Peerless, the rest of the portfolio grew strongly, 10% organic growth, well ahead of our financial model. I'll now move on to operating profit. Following a strong performance in FY25, we have again improved operating margin, up 400 basis points to 26.5%. As a result, operating profit grew by 42% to £487 million. Our volume growth has, as usual, been a strong driver of margin expansion, driving significant operating leverage benefits. Our proven ability to pass on input cost increases such as copper price and inflation through pricing is a key measure of our value-add model and the solutions we bring to our customers.

8:48 Over the last few years, our operating margins have expanded significantly. This has been driven by A, operating leverage as our businesses grow, B, continuous performance improvements through strong discipline and execution, and C, structurally improving the portfolio through high-quality acquisitions. As I've mentioned before, our margins feel like they are at the top end, so in the coming year we anticipate some margin moderation from these levels, reflecting three factors. Selective investment in OPEX to support growth. controlled moderation in peerless margins while still growing profit, and continued acquisitions to complement organic growth, which may not always be accretive to our high margin. I'll cover this more fully when I talk about the FY27 guidance.

9:41 Now on to EPS growth. I'm very pleased to report that EPS grew by 45% to 255.6 pence, an incredibly strong performance, building on our long track record of double digit growth. Organic and inorganic growth both contributed strongly to this performance. Net interest expense was a little higher year on year as acquisitions momentum stepped up. Our all-in blended cost of debt has remained consistent at 5.3%. Our effective tax rate was 25%, consistent with FY25. 45% EPS growth is a great result. Of course, we won't deliver this growth every year, but a performance like this builds our earnings base, accelerating our compounding.

10:34 Now let's turn to cash. Our capital light business model and disciplined execution allows us to drive strong and consistent cash conversion. We achieved 94% conversion, slightly above our financial model, delivering free cash flow of £323 million. We see inventory investment as an important tool to unlock growth when executed carefully and with discipline. We have deployed almost £60 million, mainly on targeted inventory investments, moderating our cash conversion a little from prior years. And we'll continue to do more of this across the group. So, we would continue to expect cash conversion around the 90% level rather than the higher levels we have seen over the last few years.

11:25 Acquisition outflow was £291 million, reflecting the strong deal momentum. Deals totalling a further £87 million have been completed in the early part of FY27. And we paid £85 million in dividends, continuing our long track record of progressive dividend growth. Taking all this together, net debt increased to £351 million with leverage maintained at 0.7 times, providing significant balance sheet capacity for further acquisitions. Let me now talk about those acquisitions. Acquisition momentum was strong through the period. In fact, we did more deals in FY26 than in any other year.

12:12 Since the start of FY26, we have completed 16 acquisitions in our core geographies and across all three sectors, investing £368 million at seven times EBIT, adding £50 million of annualised operating profit. That's over 10% of FY26 group profit. CDM, our defence platform, was the largest acquisition this year for $170 million. And since the year end, we've invested $90 million in Elite, a specialist supplier of water pump parts, also in the US, together contributing over £20 million of annualised operating profit. and we welcomed 14 other businesses to the group that give us further exposure into great end markets and drive strong returns.

13:03 We continue to demonstrate our ability to acquire high quality businesses that quickly deliver against our 20% returns hurdle. We have also demonstrated our willingness to acquire at higher multiples for strategically important assets where we see strong returns potential like CDM which we bought at 11 times. We remain focused on the right opportunities, not the number or size of deals. Our approach to acquisitions remain disciplined and returns-led. Now on to returns. Delivering disciplined returns is critical to sustainable compounding results. FY26 Roazie was 25.3% above our optimal high-teens range. Our goal is to maximise long-term value creation, and that is delivered by deploying more capital with discipline to achieve high teens' returns.

14:00 This creates significantly more value than delivering high returns percentage, but with less capital deployed. I've already mentioned some planned investments for growth in OPEX and working capital. With our strong acquisition pipeline, we also hope to bring more businesses into the group. With these continued investments, we would expect returns to moderate back to our optimal high-teens range over time. Now on to our FY27 guidance. It's been a very strong start to the year. For FY27, we expect organic growth of 6%, ahead of our financial model of 5%. It's important to note the shape of this growth across the year. We anticipate a double-digit Q1, followed by a mathematical moderation in Q2 and Q3, as we lack very strong comparatives in those quarters, which included very strong performance from peerless in FY26.

15:01 The acquisitions we've made to date will contribute 6% to revenue growth in FY27 and any other acquisitions during the year will be incremental to this. We are guiding to an operating margin of 25.5%. A continued strong performance while reflecting the factors I mentioned earlier around planned strategic investment, acquisition dilution and controlled moderation of peerless margins. So, summing it all up, FY26 has been an incredible year. I'm really pleased to be guiding to another strong year of 12% revenue growth and 25.5% margins with further EPS growth. I'll now hand back to Jonny.

15:52 Great. Thank you, Wilson. Okay, to remind you for a minute of our strategy. It's about building high quality, scalable businesses for sustainable organic growth. We drive organic growth in what I call our three buckets. positioning behind structurally growing end markets, expanding further in core developed geographies and extending our product range to expand addressable markets. Small concentrated businesses stepping out of their niche, taking their specialised proposition to new places. They all have fantastic opportunities to grow. This strategy drives exciting sustainable organic growth, scale and increased resilience.

16:39 This is complemented by selective high quality acquisitions that drive future organic growth and at great returns. Our acquisitions add to the quality and diversification of the portfolio which in turn have made the group's organic growth more structural. Our value-add model and our powerful decentralized culture are our key differentiators. And as we go from small to large, we naturally have to do things a bit differently while always preserving these differentiators. So building effective scale is key to the strategy. Developing our businesses and group to become better, not just bigger, and as such to sustain long-term delivery. The financial outcome of this strategy is sustainable quality compounding. Ambitious earnings growth combined with disciplined returns in the good times and the bad.

17:32 Let's spend a minute on growth and our first bucket, particularly end markets. Over recent years, we've considerably increased our exposure to these attractive end markets. Our products and services are relevant to so many of them. We're not dependent on any one or other. They gave us growth tailwind and resilience and they've made our growth more structural. We're making progress across all the markets on this slide. We're more developed in spaces such as aerospace, defence, IVD and they're contributing well to today's performance. I'm excited about our earlier stage markets where we're also investing and expect to see meaningful contribution to organic growth in the years ahead.

18:17 A few examples of this. Thank you very much. Population growth, climate pressure, ageing systems are all driving demand for water infrastructure, treatment and management solutions. Our products and services, particularly fluid power and sealing solutions, support this demand. We've some expertise already, particularly in Australia and through our acquisition this year of CNC packings in the US. Elite is a big step forward for us and I'll talk a little more about that in a minute.

19:09 Our exposure to data centres is small, low single digits of group revenue, and mainly through our premium cabling solutions in Windy City. We're excited about sustainable maintenance and repair potential in cooling systems. We've invested significant business development and inventory in the US and UK seals businesses, and we're winning business. These won't be significant contributors in 2027. but in the medium to long term they will sit alongside today's more developed end markets as significant contributors to our organic growth. Now let's look at the significant white space opportunity in the other two buckets, geographic penetration and product extension.

19:55 Geographically, we're focused on the core developed economies. As you can see, penetration is still very small today in our product verticals across the US, Europe and the UK. We don't need to go to higher risk developing markets for our growth. We can also add new product verticals. We don't want to go crazy with this. Portfolio focus is important, but we'll selectively ensure it suits our business model and we have the right to scale. There is plenty of white space for us to go after. Acquisitions, as you know, are important to the strategy too. They accelerate our organic growth and together with occasional selective disposals, they build the quality and the diversification of the portfolio.

20:42 We've accelerated capital deployment with 1.7 billion spent on over 60 deals in the last seven years, significantly above the financial model. But it can't be just any business at any price. We say no a lot. Discipline is critical to sustaining our compounding and that's represented by our returns, which are over 20%, as Wilson said. Thank you very much. Our discipline also means that our progress with acquisitions won't always be linear and that's okay too. Over the long term, the fundamentals support a healthy deal flow. It's a fragmented market and our short-term pipeline is stronger than ever.

21:43 Our capability and processes work and we continue to be the buyer of choice. We've had a record year. We've made a couple of exciting additions in quarter one and I'm optimistic about the future. I want to talk about the importance of scaling the group. We have a long runway of growth ahead of us, but how do we sustain our growth forever? How do we execute a greater scale? We call it our scaling strategy. Here are some of our general managers talking about key scaling themes. The key thing about scaling is that we think about tomorrow not today and that means we are thinking about an organisation that's twice as big and we're thinking about the people that can be successful in an organisation that's twice as big so that we can be ready for tomorrow.

22:34 Diploma wants growth, sustainable growth, but Diploma takes also care of your people. People is very important. Diploma will also put a more structured process on your business for getting that future growth. We're born out of a very small family business over the last 20 years. As part of that scaling journey, we need the right structure, we need the right people, we do need the right governance. We've grown our capability, our people, strengthened our processes, implemented new controls. We've relocated our headquarters to Mississauga, Ontario, in a brand new facility. While at the same time, we're renovating our facility in Edmonton. Having the two locations, one located in eastern Canada and one located in western Canada, allows us to really serve our customers closer to where they're located.

23:21 At the moment, I'm currently rolling out a new ERP system, get full traceability across our data, look at our inventory management, look at real-time information with the support of business intelligence. We have this really strong customer base and we've been thinking about scaling from a channel standpoint. And we've added a lot of technology and enhancements to our website to introduce new products, new ways to kind of service our customers. So that's allowed us to kind of enter the market to deliver that level of growth. Hardest part about scaling is not losing your magic. So you have to invest in technology, but you can't lose focus of what's most important and that's your people and your customers.

24:02 A lot of important stuff, so a bit more colour on what we're doing. We're developing our leaders, providing leadership at scale development training and hands-on support for our general managers and their leadership teams to enable them to run bigger and more complex businesses. Building great internal succession. We have a goal to internally appoint 80% of senior positions by 2030. This is key to cultural continuity and continued execution. Investing in facilities. In recent years we've invested in dozens of new and enhanced sites for our businesses, improving operational capability, customer fulfilment and efficiency through automation. That journey continues this year. Developing our diploma assurance platform.

24:49 Enhancing our control environment for a secure platform as our portfolio grows. Scaling the group. The organisational structure has plenty of capacity for scale. The portfolio and strategy remain simple and focused. Our structures are deliberately lean with exceptional dynamic leaders. And culture, we're obsessive about it. Local accountability and entrepreneurship combined with sharing across the group network and a performance-hungry ownership mindset. This is all key to the scaling journey for our businesses and the group, ensuring great execution and sustainable compounding at greater scale. So let's now review the sectors. Controls are in great shape. We've very intentionally increased our exposure to attractive growth markets over recent years, defence, aerospace, energy, adding more structural support to the sector.

25:43 With strong execution too, organic growth acceleration has been broad based. IS Group, Clarendon, Windy City and Peerless all growing double digit and with great momentum into the new year. Windy City continues to perform very well with broad based volume growth in building automation, AV and security, gas station infrastructure, digital antenna systems and data centres. IS Group and Clarendon are in great shape. Strong leadership teams, supportive end markets, great execution and exciting acquisitions too. The largest deal in the year was CDM, our US defence platform, which joined IS Group in June. Mark DiLeo and the team have settled fantastically and the business is growing double digit. Other deals in IS Group and Clarendon, Spring, Swift, SpecTech, MGC, have expanded our presence in defence and aerospace in the UK, Europe and the US.

26:42 Overall, the momentum and controls is very exciting. Peerless has had an outstanding year. The market dynamics remain unchanged and the quality of the business model and team allows us to win market share. We're investing in business development to drive long-term volume in the US and Europe. In aerospace, defence and space. We will see moderation in quarter two and quarter three particularly, in line with much tougher comps, but we're very positive about growth this year, in line with the 10-ish percent long-term track record, and profits will continue to grow too. SEALS has really good momentum, with 4% organic growth in the year and 6% in the second half. While some end markets have been tough, we've been diversifying the sector in recent years. End markets such as renewables, water, infrastructure, food and beverage, medical, have helped support the sector's performance.

27:47 And we're very excited about our prospects for the long term in nuclear, water and data centre MRO, as I said earlier. This will give seals similar tailwinds in the future that controls has today. International Seals was challenging in the UK and Europe earlier in the year but has improved with more stable market conditions. We've also invested in leadership capability improving our execution. We've supported the sector with some acquisitions in Australia and the UK which diversify end markets and product capability. International Seals has much better momentum into the new year and our execution is improving all the time. A spotlight for a moment on North American seals.

28:34 The sector has had an excellent year. Under new leadership, Neil's here with us today, with high single-digit organic growth and significant margin improvement. Our Hercules aftermarket business is serving into heavy machinery repair markets, benefiting from infrastructure investment and ageing fleets of machinery. The team are doing really well, delivering consistent double-digit profit growth. Hercules OEM has also had a fantastic year. We strengthened the team, we're upgrading facilities, and we acquired CNC packings to access the water market. And VSP, as I mentioned, has really exciting end market opportunities to execute over the next few years. We've just acquired Elite, an aftermarket water pumps business based in Louisiana and Texas.

29:24 The business gives us more exposure to the water and market. It diversifies our product capability and allows us to cross-sell with our Hercules aftermarket seals business. Chad Sensat and his team have an excellent track record and we're excited to have them in the group. Altogether, across all of seals, we're expanding our product capability to grow addressable market. We're improving our end market exposures and we're working on our execution. I feel very positive about the future. After a few good years, life sciences has been a bit tougher this year. The healthcare market has been challenging, and it shows the quality of our businesses and our teams that we've continued to perform.

30:09 The sector supplies products with defined life cycles, and we've come to the end in a few more than normal this year. Organic growth was therefore 1%, but this has been complemented by good acquisitions and margin improvement to report profit growth of 15%. Over the long term, IVD markets will attract structural investment into preventative medical testing, innovation and automated solutions. Similarly, at the premium end of MedTech, where we operate, we expect significant investment in our specialist spaces of endoscopy, urology, gynaecology and patient monitoring. Our businesses are really well positioned to take advantage of this. We've great leaders, we've invested in our business development, and there are plenty of new product opportunities coming through.

30:58 Alpha Labs and Electromed were two acquisitions we welcomed in late 2025, and they've started really well. In the last few months, we also welcomed Modal Nordic in Norway and Gitec in Australia. A good year for acquisitions, and the pipeline looks positive too. I suspect that short-term organic growth will remain modest. but I'm really confident in the long-term prospects for Life Sciences. So, summarising, it's been an excellent year for Diploma. Earnings were up 45% and a 25% return on capital. The group's organic growth runway is massive with promising end-market structural support. We're investing behind it. will continue to acquire businesses that add to the quality and diversification of the group. After a record year, we have a healthy pipeline ahead and balance sheet capacity.

31:55 We started the new year well, and after such a strong 2026, we're guiding to a very positive 2027 too. We're feeling positive about our long-term prospects. Really, we're just getting started. Sustainable quality compounding. We'll take your questions.

32:22 Thank you. Annalise Vermeulen from Morgan Stanley. Two questions please. So just a bit of an update on the M&A landscape and what you're seeing. Clearly a very busy year in terms of volume of deals. So could you talk a little bit about how your M&A capabilities have evolved in terms of sourcing and integration and then also in terms of Thank you.

33:11 Okay, I'll let Wilson do margins in a second. I'll do the M&A one. From a market perspective, I think broadly generalising, I would say the market is pretty healthy and pretty active. Probably, Steve would say, as healthy as it's been for a year or two anyway, particularly stateside, but also in Europe. It does mean also with lots of money floating around that, you know, Thank you very much. David Goode, you know huge deal flow and you've got a lot of dry powder particularly private equity dry powder you know quality businesses will start to become more expensive so it really shines a light on your discipline and while we've done more deals in the last 12 or so months Thank you very much.

34:52 So that's obviously part of the discipline. The multiples thing, we both alluded to actually earlier, it's a really important point because lower multiple doesn't mean greater discipline. People get, I think, confused about that. The discipline is about returns. and therefore, you know, while of course we're delighted that we can get 16 deals at a seven and a half times multiple and those will deliver great 20% plus returns in the next few years, we're also super aware of the fact that we could equally buy businesses at higher multiples that deliver fantastic returns too. And we've seen ourselves do that. You know, the likes of Peerless, Windy City, even CDM more recently at 11 times will deliver fantastically as well.

35:37 So the multiple is only a factor of potential and therefore from our perspective the greatest deals could be at 7 times but they could be at 11, 12, 13 times plus as well. So the discipline is about returns, it's not about multiples. So look, the market is good Our discipline is good from a kind of process perspective. We've got a fragmented market out there and the pipeline looks good. Steve's continued to build the team out. We've got a few more people on the team and we focus quite intently on making our general managers a key part of and contributing. towards the M&A process and many of them are very active on that too and they become conduits to origination as well. And of course we like to see ourselves as a good home for buyers which helps us from a discipline perspective too.

36:40 So overall market is good but a bit expensive, our discipline remains in place, our processes and our team are well positioned and the pipeline looks good.

36:51 Thank you. On the margin side, yes, so the acquisitions that we've acquired have an average operating margin of 21%, so compared to the 26.5%, clearly that will cause some dilution going into next year. The other factor is Peerless's controlled margin moderation. When we acquired the business, it was roughly 35% margin. Clearly it's a lot higher than that now. and as part of that margin moderation journey we do expect it to get to the low 40s by the time it moderates. And then finally, to the point you make, yes, as we continue to grow we get good operating leverage from our businesses and we intend to reinvest some of that into growing into end markets, people, organisation, talent, capabilities and protecting the value that we create for our shareholders through a diploma assurance platform.

37:50 Thank you.

37:53 Thank you. Good morning, it's David Brockton from Deutsche Neumann. Can I ask two, please? One on investment and then one also on the guidance for growth. In terms of investment, you set out in the presentation several areas of investment, OPEX investment and... Deliberate Inventory Investment this year. Can you maybe just elaborate on that in terms of is that spread widely across the group? Are there any particular reporting sectors that stand to benefit from that? And to what extent that sort of top-down pushed into the business or bottom-up pulled from youth, please? and then the second question just relating to the organic growth guidance I recognise the comp does get tougher through the year but I guess if you start the year with double digit and I think in the presentation you said that you think peerless should be broadly around double digit through the year it feels like there's some moderation elsewhere and is that sort of inherent conservatism obviously it's early in the year or is it any other areas within the business that could see some moderation through the year ahead? Thank you.

38:56 and they're both yours Wilson. Great.

38:59 Look I think it's a great position to be in where we've got lots of opportunities to invest for further sustainable growth. I've talked about the OPEX investments that we will be making. And clearly, working capital, particularly inventory, we are continually investing to grow in the buoyant markets that we're currently already in, aerospace, defense, energy. And also, with regards to the new end markets that we want to penetrate, places like water, data centers, etc., and it's also important to recognize that as we continue growing very rapidly, inventory investment is needed to ensure that we maintain customer service levels as well. So with these targeted investments into the very high growth businesses with discipline, we do expect cash conversion to moderate in the future. Thank you, David, for asking that question.

40:01 It's a very important point. clearly FY26 was a very strong year and we've got very tough comps to lap Q1 will be very strong particularly because Q1 last year was the weakest quarter for us and we come into this year with very strong momentum. Q2 and Q3 were the strongest quarters for us last year with meaningful performance from peerless as well. And even though peerless's run rates are expected to continue to be strong this year, that will give us a mathematical moderation as we go into Q2 and Q3.

40:54 There's also impacts from things like working days, Easter and how it lands, for example. But finally, you know, we just need to be thoughtful. The year is long. There's a lot that could happen. But saying that, let's take a step back, put it into context. We've just done a year of 15% organic growth, 45% EPS growth. We're guiding to an incredibly positive 6% organic growth still. That's ahead of the model. So I think overall, it's a very, very positive guidance.

41:34 Thanks. Good morning. It's Tim Ramsgill from Bank of America. Two questions, please. The first is just around, you obviously have the BM&A kind of matrix of end markets and products. And Johnny, you alluded to sort of maybe product categories that you'd look to get into. Just interested in thoughts there as to, is that related to products you don't have today in your suite of controls and seals that you kind of wish you had and you can see the opportunity? and then also related to M&A I guess over time it might well become the case that some of your businesses perform a little less well so how integrated do your businesses become and kind of what are your thoughts longer term on whether there's going to be portfolio management or any need to ever make sort of modest disposals at the margins.

42:20 Thanks.

42:21 Okay, I think these are probably both mine. Can I do them in reverse order? Disposals, I guess, was your second question. I think it's important for me to reiterate, I suppose, our internal mindset for assessing the portfolio from this perspective. First of all, It's an important discipline that we're always looking at the portfolio. I think capital allocation means not just how you acquire, it means making sure that you're constantly assessing the quality of your current portfolio and we continue to do that. As you know, we had a couple of years Thank you very much.

43:32 We don't look to sell a business because it isn't performing in a particular year. That's just the cycle or our job to fix performance. We look at and assess the portfolio based on is it the right business model for us in the long term? and are we the rightful people to grow and scale it over the long term? So much, much more structural questions we ask and of course if the answer is no to those or both of those then that would raise a flag but when it comes to performance then it's just our job to manage. So that's the portfolio question.

44:08 The other one was about acquisitions and expanding, I suppose, white space.

44:13 I think the first thing I'd say is it's primarily organic. Yes, with acquisitions, of course, as well. But it's worth me saying that the end market geography product buckets are... Thank you very much. in acquisitions at the lens of does it give us a particular end market? Does it give us a new product or a particular product angle? Does it get us into a geography that we really want to be in?

44:58 If I look at maybe taking Elite as an example of this just to give you a bit of colour, Elite really ticks for us all the boxes because it gets us into the water market in a more meaningful way. and that's a place that we really want to do a bit more in. So that's an exciting end market tick. Geographically, we're a bit under on the south, Texas and Louisiana, which we believe particularly Texas is going to be, is and will continue to be high growth states of the US. So we're very happy to have a bit more presence there. And product wise, your aftermarket pump parts are, it doesn't sound very sexy does it, but particularly exciting for us because it's new product and it's also complementary to some of our aftermarket seals products as well.

45:50 So if you think about your question and our three buckets, there's an example of an acquisition which ticks. all three. Now not every acquisition does tick all three. Some will tick one or some will tick two but we're always looking at it through that lens and therefore quietly over time you just start to fill in a little bit more of that very white space slide.

46:25 Morning both. James Bayliss from Berenberg. Just two ones. On that 80% of senior appointments to be made by 2030 from an internal perspective, can you give us a sense of where you are now and is that just a case of the development strategies in place taking some time to bed in or are there any step changes you need to be thinking about to get up to that level? And then point number two is just Pardon me. With regard to aerospace, can you give us an update or any kind of further thoughts on Swift Aerospace and the European opportunity you have in the division there? Thanks.

47:01 Yeah, okay. Let me tackle the 80% succession thing first. I'm glad you've asked it James, thank you. It's probably one of the most important objectives that we have internally and Donna is sitting just in front of you smiling like a Cheshire cat because you asked that question so thank you. Really, really important. If you look at all great very large compounders management succession is always a critical underpin to their success. Continuity of culture, continuity of execution, really, really important to diversify compounders. So recognizing that, We've made it an objective.

47:49 Now, it would probably have been very difficult for us to do it any sooner two, three, four years ago because the nature of our very small businesses means that it's quite difficult to get a lot of succession in there. But now our businesses are getting a bit bigger. They can afford to have much broader, deeper management teams. And therefore, as you know, last year we decided for ourselves that this was going to be a very, very important objective for us. And all of the executive team have this objective to build succession. We started with the most important role for us, which is the general manager. And we started during the course of 2026 to work through that.

48:34 And we've made a lot of great progress it's one of those things that will never end you're constantly working on it so we're not sitting here saying we're suddenly perfect but we've made a lot of great progress and of course as a result of it we're starting to build more and more capability and bench into the management teams and with things like the graduate program building more further down the organization with spotlights into our high potential people as well to complement that getting more visibility further down. So look, we're early on that journey but we've given ourselves a really bold target and we're all pretty motivated by it because we recognise its importance. The second question was about aerospace and specifically about, I think, SWIFT and Europe.

49:26 Maybe if I can just broaden it a little bit because aerospace is obviously an important sector for us. and Europe and not just but partly the Airbus supply chain are a very important part of that. Actually, we think we've got opportunities across all of our aerospace into Europe. Swift has been a great stepping stone for Clarendon. and many more. Thank you. Next.

50:41 First on life sciences, can you help us understand the impact on organic growth of the product portfolio effects? How much growth revenue has been lost? And then the second is on copper and Windy City. Roughly how much did it help organic growth in the year and can you remind us of the mechanism for passing through copper in pricing?

51:05 Yeah, so I think life sciences, just to put it into context, healthcare markets have been tough. And I think enough said to say, you know, you've seen the H2 organic growth for life sciences. That probably explains sort of, you know, the performance at present. But, you know, it's important to mention that This is inherently a product lifecycle business. So in any given year, there will be products coming out of the portfolio, but then new products ramping up into the portfolio as well. And the same happened when we were doing 6% growth in three consecutive years previously.

51:50 So I guess FY26, just to put it in context, we've just seen a bit more of products coming out, but it is a phasing thing, partly because the healthcare market is a bit tougher. But let's not take anything away from the sector. We've continued to invest in it. Revenue growth was 12%, profit growth was 15%, and we've improved the operating margin by 50 bps to 20% in FY26. So I think going into H1 short term, it will still be a bit challenging, but the product pipeline is very healthy and it's great outlook for the future. In terms of Windy City Wire, did 19% growth last year. Roughly half of it was the benefit of copper pricing, but it's also a testament to the strength, the muscle memory of the team managing that dynamic copper pricing, being able to pass it on successfully.

52:51 And to be honest, it's nothing new. It's part of the bread and butter and the business as usual for the business. And going into next year, see a bit of copper softening at the moment. It may take a bit edge off the top line, but minimal negligible impact on profits.

53:18 Any more? No? Thank you all very much for joining us. Have a good rest of the day.

Follow Diploma PLC into a list and get an email when it puts out news.

Latest news releases

Companies on this call

Speakers

Wilson Ng

Chief Financial Officer

David Brockton

Analyst, Deutsche Numis

Tim Ramskill

Analyst, Bank of America

Annalise Vermeulen

Analyst, Morgan Stanley

James Bayliss

Analyst, Berenberg

Johnny Thomson

Chief Executive Officer

More from Diploma PLC